Seres Therapeutics (NASDAQ:MCRB) Stock Price Up 8.5%

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating)’s share price rose 8.5% on Tuesday . The company traded as high as $6.25 and last traded at $6.23. Approximately 1,791,792 shares traded hands during trading, a decline of 16% from the average daily volume of 2,130,646 shares. The stock had previously closed at $5.74. Wall Street Analyst […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Noubarb Afeyan ,Davida Berry , ,Canaccord Genuity Group ,Securities Exchange Commission ,Nasdaq ,Flagship Pioneering Inc ,Sit Investment Associates Inc ,Seres Therapeutics Inc ,Fund Management Co ,Jpmorgan Chase Co ,Connor Clark Lunn Investment Management Ltd ,Seres Therapeutics ,Get Rating ,Therapeutics Stock Down ,Exchange Commission ,Investment Associates ,Fund Management ,Lunn Investment Management ,Flagship Pioneering ,Seres Therapeutics Daily ,